Abbott's (NYSE: ABT) newest sensor-based glucose technology, the FreeStyle Libre 3 Plus* sensor, is now publicly funded in ...
Abbott is tapping the spirit of new beginnings for the New Year by unveiling a “gamechanger" feature within the company’s ...
Abbott (NYSE:ABT) today unveiled a new feature within its FreeStyle Libre app for continuous glucose monitoring (CGM).
Zacks Investment Research on MSN
Is it the right time to add Insulet stock to your portfolio?
Insulet PODD is well-poised to grow in the coming quarters due to the strength of its Omnipod 5 platform. The company is strongly executing against its long-term priorities to drive penetration, ...
Abbott, the creator of continuous glucose monitors, launched the new Assist feature at CES 2026. Part of the Libre app, it ...
Abbott (NYSE: ABT), a leading healthcare company, today unveiled Libre Assist,1 a groundbreaking feature within the Libre ...
The latest version of Samsung's little projector now has AI, because of course it does.
Samsung’s Freestyle Plus projector debuts at CES 2026 with a wall calibration feature that cancels out wall patterns for a ...
4d
Samsung's popular Freestyle projector is getting several useful upgrades - and I'm tempted to buy it
Samsung has unveiled the latest version of its Freestyle portable projector, and if it follows the same path as earlier ...
Abbott has launched Libre Assist, a feature within the Libre app designed to help people living with diabetes better understand how the foods they eat affect their glucose levels.
The Freestyle Plus all-in-one portable projector features 430 ISO lumens, or “nearly twice the brightness of the previous ...
The Freestyle+ makes Samsung's popular compact projection solution even easier to set up and use in even the most difficult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback